보통사마귀 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.8%로 성장할 전망이며, 28억 3,000만 달러로 성장이 예측됩니다. 예측 기간 동안 성장은 노인 인구 증가, 바이러스 감염증 유행, 선진 피부과 치료 채용 증가, 맞춤형 치료에 대한 수요 증가, 재택 케어 솔루션에 대한 소비자 기호 증가 등의 요인에 기인할 것으로 보입니다. 이 기간 주요 동향으로는 피부과 치료 진보, 헬스케어 인프라의 확대, 사마귀 제거 치료에 있어서 기술 혁신, 이용 가능한 치료 옵션 인지도 향상, 저침습 치료에 대한 시프트 등을 들 수 있습니다.
바이러스 감염 증가는 향후 수년간 보통사마귀 시장의 성장을 가속할 것으로 예측됩니다. 바이러스 감염증은 체내에 침입, 증식, 확산되는 바이러스에 의해 야기되는 질환으로 세포나 면역 반응에 영향을 줍니다. 이러한 감염병의 만연은 세계화, 기후변화, 도시화, 삼림벌채, 면역력 저하 등의 요인에 영향을 받고 있습니다. 보통사마귀 치료는, 사마귀 형성의 원인이 되는 인유두종 바이러스(HPV)를 표적으로 해, 바이러스의 감염을 억제해, 불쾌감을 완화하고, 치유를 촉진하는 것으로, 바이러스 감염 환자에게 중요한 서포트를 제공합니다. 이를 통해 2차 감염이나 흉터화 등의 합병증을 예방하고 환자 삶의 질을 향상시킬 수 있습니다. 예를 들어 2024년 미국 질병예방관리센터는 2022년 PCR로 확인된 수두 사례 비율이 62% 증가했고, 지난 5년간 29%에서 47%로 증가했다고 보고했습니다. 이어 2023년 1월 전미감염병재단은 미국에서 연간 약 1400만 건의 HPV 감염 사례가 새롭게 발생하고 있다고 지적했습니다. 그 결과 바이러스 감염증의 이환율 상승이 보통사마귀 시장의 성장을 촉진하고 있다.
보통사마귀 시장의 주요 기업은 효과적이고 사용하기 쉬운 솔루션에 대한 수요 증가에 대응하기 위해 피부과 치료와 같은 혁신적인 치료의 진전에 주력하고 있습니다. 이러한 치료는 환자의 예후를 개선하고 피부과 분야에서 시장 존재를 확대하는 것을 목적으로 하고 있습니다. 피부과 치료는 감염, 염증, 장애를 포함한 피부 질환의 치료를 말합니다. 예를 들면, 2024년 5월, 미국의 제약회사 Verrica Pharmaceuticals는, 일본의 제약회사인 토리이 약품 주식회사와 라이센스 계약을 체결했습니다. 이 제휴는 세계의 치료제 개발에 자금을 제공하는 것을 목적으로 하고 있습니다. 이 제휴는, 보통사마귀의 치료약인 YCANTH의 국제 공동 제3상 임상시험에 자금을 제공하기 위한 것입니다. 본 계약은 YCANTH의 후기 개발을 지원하고, 보다 광범위한 세계 시장으로의 참가를 지원하는 것입니다. 도리이약품은 양사의 피부과 영역에서의 포트폴리오를 강화하고 국제적인 위상을 확대하기 위해 본시험을 지원하는 자금을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 보통사마귀 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 보통사마귀 시장 : 성장률 분석
- 세계의 보통사마귀 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 보통사마귀 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 보통사마귀 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 보통사마귀 시장 : 치료 방법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 동결요법
- 레이저 치료
- 전기 수술 수술
- 외용약
- 세계의 보통사마귀 시장 : 환자 인구 통계별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 아이들
- 성인
- 노인
- 세계의 보통사마귀 시장 : 질병의 스테이지별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 초기
- 중등도
- 중증기
- 세계의 보통사마귀 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 피부과 클리닉
- 홈케어
- 세계의 보통사마귀 시장 : 동결요법 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 액체 질소 요법
- 이산화탄소 요법
- 세계의 보통사마귀 시장 : 레이저 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 펄스 색소 레이저 치료
- 이산화탄소(CO2) 레이저 치료
- 세계의 보통사마귀 시장 : 전기외과 수술 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 소파술과 전기외과 수술에 의한 제거
- 고주파 전기 수술 절제
- 세계의 보통사마귀 시장 : 외용약 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 살리실산계 요법
- 면역요법 기반 외용약
- 레티노이드 기반 요법
제7장 지역별 및 국가별 분석
- 세계의 보통사마귀 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 보통사마귀 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 보통사마귀 시장 : 경쟁 구도
- 보통사마귀 시장 : 기업 프로파일
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- GlaxoSmithKline plc 개요, 제품 및 서비스, 전략 및 재무 분석
- Sun Pharmaceutical Industries Limited 개요, 제품 및 서비스, 전략 및 재무 분석
- Perrigo Company plc 개요, 제품 및 서비스, 전략 및 재무 분석
- Holland & Barrett International Limited 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Prestige Consumer Healthcare Inc.
- Maruho Co. Ltd.
- Novan Inc.
- X4 Pharmaceuticals Inc.
- Aclaris Therapeutics Inc.
- Verrica Pharmaceuticals Inc.
- RXi Pharmaceuticals Corporation
- Scholl's Wellness Company
- Nielsen BioSciences Inc.
- Cassiopea SpA
- Orgenesis Inc.
- KinoPharma Inc.
- Naturasil
- Veradermics Inc.
- KinoPharma Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 보통사마귀 시장(2029년) : 새로운 기회를 제공하는 국가
- 보통사마귀 시장(2029년) : 새로운 기회를 제공하는 부문
- 보통사마귀 시장(2029년) : 성장 전략
제36장 부록
AJY
Common warts are non-cancerous skin growths caused by the human papillomavirus (HPV). They typically appear on the hands, fingers, and other areas, acting as a defense mechanism for the body in response to the viral infection.
The main treatment options for common warts include cryotherapy, laser treatment, electrosurgery, and topical medications. Cryotherapy is a treatment that uses extreme cold, usually liquid nitrogen, to freeze and destroy abnormal tissue. These treatments are provided across various patient demographics, including children, adults, and the elderly. Treatment approaches vary depending on the stage of the condition, with options tailored for the initial, moderate, or severe stages. These treatments are administered in various settings, such as hospitals, dermatology clinics, and home care.
The common warts market research report is one of a series of new reports from The Business Research Company that provides common warts market statistics, including the common warts industry global market size, regional shares, competitors with the common warts market share, detailed common warts market segments, market trends, and opportunities, and any further data you may need to thrive in the common warts industry. These common warts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The common warts market size has grown strongly in recent years. It will grow from $2.13 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be attributed to factors such as increased awareness of skin health, a rising incidence of warts, growing demand for non-invasive procedures, the increasing use of cryotherapy, and the expansion of dermatology clinics.
The common warts market size is expected to see strong growth in the next few years. It will grow to $2.83 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period can be attributed to factors such as the rising geriatric population, the growing prevalence of viral infections, increased adoption of advanced dermatological therapies, a growing demand for personalized treatments, and a higher consumer preference for homecare solutions. Key trends during this period include advancements in dermatological treatments, expanding healthcare infrastructure, technological innovations in wart removal treatments, greater awareness of available treatment options, and a shift towards minimally invasive treatments.
The rising occurrence of viral infections is expected to drive the growth of the common warts market in the coming years. Viral infections are diseases caused by viruses that enter, multiply, and spread within the body, affecting cells and immune responses. The growing prevalence of these infections is influenced by factors such as globalization, climate change, urbanization, deforestation, and weakened immune systems. Common warts treatments target the human papillomavirus (HPV) responsible for wart formation, providing vital support for viral infection patients by reducing virus transmission, easing discomfort, and promoting healing. This helps prevent complications such as secondary infections or scarring while improving the patient's quality of life. For example, in 2024, the Centers for Disease Control and Prevention reported that, in 2022, the proportion of PCR-confirmed varicella cases rose by 62%, increasing from 29% to 47% over the past five years. Additionally, in January 2023, the National Foundation for Infectious Diseases noted that there are an estimated 14 million new cases of HPV infection annually in the United States. As a result, the rising incidence of viral infections is driving growth in the common warts market.
Key players in the common warts market are focusing on advancing innovative treatments, such as dermatological therapies, to address the growing demand for effective and accessible solutions. These treatments aim to improve patient outcomes and expand market presence in the dermatology sector. Dermatological therapies refer to treatments for skin conditions, including infections, inflammations, and disorders. For instance, in May 2024, Verrica Pharmaceuticals, a U.S.-based pharmaceutical company, entered into a licensing agreement with Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company. This collaboration is designed to fund a global Phase 3 clinical trial for YCANTH, a treatment for common warts. The agreement supports the late-stage development of YCANTH, helping it reach a broader global market. Torii Pharmaceuticals will contribute financial resources to support the study, which will enhance both companies' dermatology portfolios and expand their international presence.
In June 2023, Vial, a U.S.-based clinical trial management organization, partnered with Nielsen BioSciences to conduct a Phase 3 clinical trial for CANDIN. This collaboration is aimed at further developing CANDIN as a potential treatment for common warts by evaluating its safety and efficacy. Nielsen BioSciences, a U.S.-based biotechnology company specializing in immune-based therapies, is helping advance CANDIN as a promising treatment option.
Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl's Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.
North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in common warts report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the common warts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The common warts market consists of revenues earned by entities by providing services such as telemedicine consultations, therapy services, and surgical excision. The market value includes the value of related goods sold by the service provider or included within the service offering. The common warts market also includes sales of over-the-counter (OTC) treatments, prescription medications, and medical devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Common Warts Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on common warts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for common warts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The common warts market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Method: Cryotherapy; Laser Treatment; Electrosurgery; Topical Medications
- 2) By Patient Demographics: Children; Adults; Elderly
- 3) By Disease Stage: Initial Stage; Moderate Stage; Severe Stage
- 4) By End User: Hospitals; Dermatology Clinics; Home Care
- Subsegments:
- 1) By Cryotherapy: Liquid Nitrogen Therapy; Carbon Dioxide Therapy
- 2) By Laser Treatment: Pulsed-Dye Laser Therapy; Carbon Dioxide (CO2) Laser Therapy
- 3) By Electrosurgery: Curettage And Electrosurgical Removal; High-Frequency Electrosurgical Ablation
- 4) By Topical Medications: Salicylic Acid-Based Therapy; Immunotherapy-Based Topicals; Retinoid-Based Therapy
- Companies Mentioned: AbbVie Inc.; GlaxoSmithKline plc; Sun Pharmaceutical Industries Limited; Perrigo Company plc; Holland & Barrett International Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Common Warts Market Characteristics
3. Common Warts Market Trends And Strategies
4. Common Warts Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Common Warts Growth Analysis And Strategic Analysis Framework
- 5.1. Global Common Warts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Common Warts Market Growth Rate Analysis
- 5.4. Global Common Warts Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Common Warts Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Common Warts Total Addressable Market (TAM)
6. Common Warts Market Segmentation
- 6.1. Global Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cryotherapy
- Laser Treatment
- Electrosurgery
- Topical Medications
- 6.2. Global Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Children
- Adults
- Elderly
- 6.3. Global Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Initial Stage
- Moderate Stage
- Severe Stage
- 6.4. Global Common Warts Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Dermatology Clinics
- Home Care
- 6.5. Global Common Warts Market, Sub-Segmentation Of Cryotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Liquid Nitrogen Therapy
- Carbon Dioxide Therapy
- 6.6. Global Common Warts Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pulsed-Dye Laser Therapy
- Carbon Dioxide (CO2) Laser Therapy
- 6.7. Global Common Warts Market, Sub-Segmentation Of Electrosurgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Curettage And Electrosurgical Removal
- High-Frequency Electrosurgical Ablation
- 6.8. Global Common Warts Market, Sub-Segmentation Of Topical Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Salicylic Acid-Based Therapy
- Immunotherapy-Based Topicals
- Retinoid-Based Therapy
7. Common Warts Market Regional And Country Analysis
- 7.1. Global Common Warts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Common Warts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Common Warts Market
- 8.1. Asia-Pacific Common Warts Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Common Warts Market
- 9.1. China Common Warts Market Overview
- 9.2. China Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Common Warts Market
- 10.1. India Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Common Warts Market
- 11.1. Japan Common Warts Market Overview
- 11.2. Japan Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Common Warts Market
- 12.1. Australia Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Common Warts Market
- 13.1. Indonesia Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Common Warts Market
- 14.1. South Korea Common Warts Market Overview
- 14.2. South Korea Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Common Warts Market
- 15.1. Western Europe Common Warts Market Overview
- 15.2. Western Europe Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Common Warts Market
- 16.1. UK Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Common Warts Market
- 17.1. Germany Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Common Warts Market
- 18.1. France Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Common Warts Market
- 19.1. Italy Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Common Warts Market
- 20.1. Spain Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Common Warts Market
- 21.1. Eastern Europe Common Warts Market Overview
- 21.2. Eastern Europe Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Common Warts Market
- 22.1. Russia Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Common Warts Market
- 23.1. North America Common Warts Market Overview
- 23.2. North America Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Common Warts Market
- 24.1. USA Common Warts Market Overview
- 24.2. USA Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Common Warts Market
- 25.1. Canada Common Warts Market Overview
- 25.2. Canada Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Common Warts Market
- 26.1. South America Common Warts Market Overview
- 26.2. South America Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Common Warts Market
- 27.1. Brazil Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Common Warts Market
- 28.1. Middle East Common Warts Market Overview
- 28.2. Middle East Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Common Warts Market
- 29.1. Africa Common Warts Market Overview
- 29.2. Africa Common Warts Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Common Warts Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Common Warts Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Common Warts Market Competitive Landscape And Company Profiles
- 30.1. Common Warts Market Competitive Landscape
- 30.2. Common Warts Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Perrigo Company plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Holland & Barrett International Limited Overview, Products and Services, Strategy and Financial Analysis
31. Common Warts Market Other Major And Innovative Companies
- 31.1. Prestige Consumer Healthcare Inc.
- 31.2. Maruho Co. Ltd.
- 31.3. Novan Inc.
- 31.4. X4 Pharmaceuticals Inc.
- 31.5. Aclaris Therapeutics Inc.
- 31.6. Verrica Pharmaceuticals Inc.
- 31.7. RXi Pharmaceuticals Corporation
- 31.8. Scholl's Wellness Company
- 31.9. Nielsen BioSciences Inc.
- 31.10. Cassiopea S.p.A.
- 31.11. Orgenesis Inc.
- 31.12. KinoPharma Inc.
- 31.13. Naturasil
- 31.14. Veradermics Inc.
- 31.15. KinoPharma Co. Ltd.
32. Global Common Warts Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Common Warts Market
34. Recent Developments In The Common Warts Market
35. Common Warts Market High Potential Countries, Segments and Strategies
- 35.1 Common Warts Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Common Warts Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Common Warts Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
